The GeneSight Analgesic test analyzes how your genes affect the way your body may respond to FDA-approved medicines commonly prescribed to treat acute or chronic pain. The information from the GeneSight test can help your healthcare provider select the medicine(s) and dose(s) that are best suited to your condition and genetic makeup. Medicines that align well with your genes may work better with fewer side effects.
The test gives clinicians a multi-gene pharmacogenomics tool to guide medication decisions for patients with acute or chronic pain using patients’ own genetic profiles to help determine their potential response to 22 medications across four relevant medication classes: opioids, NSAIDs, muscle relaxants, and opioid dependency.
GeneSight is based on pharmacogenomics—the study of how genes affect a person’s response to medicines. The test was developed in the Assurex Health clinical laboratory and is based on patented technology licensed from two world renowned medical centers, Mayo Clinic and Cincinnati Children’s Hospital Medical Center, both of whom continue to be research collaborators.
Working with their
patients have used
GeneSight to help
find the right
treatment for them
Now you can stop wondering which medicine may help you, or stop trying several different medicines to find the one that could work. With GeneSight, your healthcare provider can take a very personalized approach to prescribing the right medicine for you.
Ready to talk to your healthcare provider about GeneSight?